Related Experiment Video
Updated: May 2, 2026

05:33
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
Published on: July 11, 2025
1.5K
AI-BLADE toolbox: AI-powered BLADdEr multiparametric MRI analysis for clinical application
Muhammad Awais1, Ramesh Paudyal1, Oguz Akin2
1Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.
BJR Artificial Intelligence
|May 1, 2026
Summary
We developed AI-BLADE, a user-friendly toolbox for bladder multiparametric MRI analysis. This tool extracts quantitative imaging biomarkers to improve bladder cancer diagnosis and patient outcomes.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Oncology
Background:
- Growing need for user-friendly, bladder-specific AI tools for quantitative imaging biomarkers (QIBs) from multiparametric MRI (mpMRI).
- Current tools lack reliability for clinical applications in bladder cancer (BCa).
Purpose of the Study:
- To develop and validate AI-BLADE (AI-powered BLADdEr multiparametric MRI Analysis for Clinical Application), a novel toolbox for BCa mpMRI analysis.
- To extract reliable AI-QIBs for enhanced clinical decision-making.
Main Methods:
- AI-BLADE integrates Deep Feature Analysis (MRI-DFA) and Data-Driven Model-Based Analysis (MRI-MBA) toolkits.
- DFA classified BCa histology subtypes (n=104) using T2-weighted images.
- MBA derived mpMRI QIBs (ADC, Ktrans) from 34 BCa patients.
Main Results:
- The VGG19 model with a decision tree classifier achieved an AUC of 0.79 for BCa histology classification.
- Mean ADC values were 1.22 × 10⁻³ mm²/s and mean Ktrans values were 0.27 min⁻¹.
- AI-BLADE demonstrated strong performance in classifying BCa subtypes and deriving key physiological metrics.
Conclusions:
- AI-BLADE (v1.0) is a flexible, user-friendly software for mpMRI analysis in BCa oncology.
- The toolbox shows potential to enhance diagnostic accuracy and improve patient outcomes.
- This novel AI toolbox facilitates AI-QIB-based clinical decision-making for BCa patients.

